Comparative Effectiveness and Safety of Intrauterine Contraception and Tubal Ligation
/
February 23, 2022
Journal of General internal Medicine
Studies about
IUDs (Intra-Uterine Devices)
Petition by Natural Womanhood
/
Sign this petition by the Contraceptive Study Group and Natural Womanhood.
Read MoreDepressive Disorder With Panic Attacks After Replacement of an Intrauterine Device Containing Levonorgestrel: A Case Report
/
Read MoreWith this case, we strengthen previous observations regarding mood changes under LNG-IUS. Moreover, we illustrate that psychiatric symptoms may also occur as ADRs during the subsequent insertion. Thus, we emphasize that psychiatric symptoms have to be clearly communicated as ADRs to patients with LNG-IUS within a written informed consent and should be routinely examined by gynecologists.
“$231 … to pull a string!!!” American IUD users’ reasons for IUD self-removal: An analysis of internet forums
/
Read MoreThis study describes the reasons for IUD self-removal as documented in internet forums by IUD users discussing self-removal.
Copper intrauterine device use and HIV acquisition in women: A systematic review
/
Read MoreThe collective evidence, including that from a large high-quality RCT, does not indicate an increased risk of HIV acquisition among users of Cu-IUDs. human immunodeficiency virus; intrauterine devices.
Levonorgestrel IUD: is there a long-lasting effect on return to fertility?
/
Read MoreGiven the current gap in the literature and trends in LNG-IUD use in nulliparous young women, studies are needed that specifically look at the interaction of nulliparity, long-term use of LNG-IUD, and return to normal fertility. Herein, we review the available literature on the mechanism of action of IUDs with a specific focus on the effect on endometrial gene expression profile changes associated with IUDs.
Effects of Hormonal Contraceptives on Mood: A Focus on Emotion Recognition and Reactivity, Reward Processing, and Stress Response
/
https://www.springer.com/journal/11920
Read MoreAccess to IUD removal: Data from a mystery-caller study
/
Read MoreIn our current climate focused on improving access to IUDs, it is essential to address and reduce barriers to IUD removal when desired, in order to preserve reproductive autonomy.
Contraception counseling for women with premenstrual dysphoric disorder (PMDD): current perspectives
/
Read MoreProgestin-only methods including the progestin-only pill (POP), levonorgestrel (LNG) IUD, etonorgestrel implant or depot medroxyprogesterone acetate (DMPA) have the potential to negatively affect mood symptoms for women with or without baseline mood disorders, including PMDD. Careful counseling and close follow-up is recommended for patients with PMDD seeking these contraceptive methods.
Routine Pathology for Intrauterine Devices and Therapeutic Abortion: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines
/
Read MoreNo conclusions can be made regarding the clinical utility of routine pathology for removed intrauterine devices or cost-effectiveness of routine pathology for therapeutic abortion or removed intrauterine devices, due to the lack of literature identified for these questions. No guidelines regarding routine pathology for removed intrauterine devices were identified. As such, no conclusion can be made.
Assessment of reasons of discontinuation of long acting reversible contraceptives (LARC) among married women visiting at Holy Family Hospital Rawalpindi. JSOGP 2016
/
Read MoreReasons for discontinuation of IUD:
Bleeding Pattern (27.5%), Pain (25%), Weight Gain (5%); Other Reasons (42.5%)
Systematic Review of Postfertilization Effects and Potential for Embryo Formation and Loss during the Use of Intrauterine Devices
/
Read MoreThere are no randomized trials and evidence ranges in quality, but evidence for the embryo formation and loss in 4.5 percent of IUD users exists in good-quality research. Further research is needed to compare embryo loss in IUD users to loss in controls.
Citizen Petition for Hormonal Contraceptives
/
Read More....The strongest data appear to be the deleterious effects of levonorgestrel-releasing IUDs on percent lean and fat body mass.
….Use of the levonorgestrel-releasing IUD, commonly used to treat abnormal bleeding in the perimenopause, increased the risk of developing breast cancer in postmenopausal women
Perinatal outcomes including long-term neuropsychiatric hospitalizations of offspring conceived during intrauterine contraceptive device use
/
Read MorePregnancies in women who conceive with a removed or retained copper IUD are at an increased risk for short-term adverse perinatal outcomes, especially preterm delivery. For pregnancies that continued to at least 22 weeks, we found no benefit in IUD removal. However, the risk of long-term neuropsychiatric hospitalizations is not increased among offspring of these women.
One-year continuation of postpartum intrauterine contraceptive device: findings from a retrospective cohort study in India
/
Read MoreAmong women who had their PPCuIUD removed, almost two thirds (64.9%) cited associated side effects like bleeding, pain in abdomen and discharge as the primary reason for removal.
Steroid reservoir loss during removal of perforated Levonorgestrel 52 mg intrauterine device
/
Read MoreA 22-year-old G1P1 Caucasian female had hysteroscopic removal of a perforated intrauterine device during which the steroid reservoir of the intrauterine device was lost. Isolated steroid reservoirs are radiolucent on plain film radiography. We located the reservoir in the peritoneal cavity with magnetic resonance imaging and removed it via laparoscopy.
Pelvic pain and early IUD discontinuation: a prospective cohort study
/
Read MoreBaseline generalized pelvic pain may not be a risk factor for IUD discontinuation within one year of placement.
Examining Long-Acting Reversible Contraception Non-Use Among Australian Women in Their 20s: Findings From a Qualitative Study
/
Read MoreAmong participants, the intrauterine device (IUD) was viewed particularly unfavourably. Furthermore, LARC was shown to be only considered for use after dissatisfaction with shorter-term methods (usually the Pill) if at all. Overall, these findings suggest further education in dispelling myths and discomfort around LARC use, while simultaneously recognizing and respecting women’s decisions to not use LARC methods.